SUBMISSION AND REVIEW DATES AND TIMES
• Pre-Application Submission Deadline: 5:00 p.m. Eastern time (ET), July 23, 2013
• Application Submission Deadline: 11:59 p.m. ET, August 6, 2013
• Peer Review: September – October 2013
• Programmatic Review: February 2014
All applications for PRMRP funding must specifically address at least one of the Topic Areas as directed by Congress, and must be directly relevant to the health care needs of the military service members, Veterans, and/or beneficiaries. If the proposed research does not specifically address at least one of the FY13 PRMRP Topic Areas, the Government reserves the right to administratively withdraw the application. The Government also reserves the right to reassign the application’s Topic Area if submitted under an inappropriate Topic Area. The FY13 PRMRP Topic Areas are listed below.
• Chronic Kidney Disease
• Chronic Migraine and Posttraumatic Headaches
• Composite Tissue Transplantation
• DNA Vaccine Technology for Postexposure Prophylaxis
• Food Allergies
• Fragile X Syndrome
• Hereditary Angioedema
• Inflammatory Bowel Disease
• Interstitial Cystitis
• Nanomedicine for Drug Delivery Science
• Polycystic Kidney Disease
• Post-Traumatic Osteoarthritis
• Pulmonary Hypertension
• Rheumatoid Arthritis
The intent of the PRMRP Discovery Award is to support innovative, untested, high-risk/ potentially high-reward concepts, theories, paradigms, and/or methods. Studies supported by this award are expected to lay the groundwork for future avenues of scientific investigation. The proposed research project should include a well-formulated, testable hypothesis based on strong scientific rationale and study design.
The proposed research project should be novel and innovative. Innovative research may introduce a new paradigm, challenge existing paradigms, look at existing problems from new perspectives, or exhibit other highly creative qualities. Research that is an incremental advance upon published data is not considered innovative and is not consistent with the intent of this award mechanism.
Inclusion of preliminary data is strongly discouraged. READ MORE